论文部分内容阅读
一、毒死蜱供应偏紧我国毒死蜱原药生产企业有十多家,总产能约达10万吨/年,国外毒死蜱的生产能力约为5万吨,主要集中在陶氏益农、马克西姆-阿甘和印度的格达和米苏等公司。2016年我国毒死蜱开工率徘徊在35%左右,供应量缩减,而2016年全年的市场销售量约4~5万吨,2017年以来虽然我国毒死蜱开工逐渐恢复,目前整体开工率徘徊在45%左右,但短期内供应仍难以满足市场需求。(见图1、表1)
First, the tight supply of chlorpyrifos China’s chlorpyrifos original drug manufacturers dozen, with a total capacity of about 100,000 tons / year, the overseas production capacity of chlorpyrifos is about 50,000 tons, mainly in Dow AgroSciences, Maxim - Forrest Gump and India, Georgia and Miss Su and other companies. In 2016, the operating rate of chlorpyrifos in our country hovered around 35% and the supply was reduced. In 2016, the annual market sales were about 40,000-500,000 tons. Since the start of chlorpyrifos recovery in China since 2017, the overall operating rate hovers around 45% However, supply in the short term is still hard to meet market demand. (See Figure 1, Table 1)